Dr. Charles G. Skardarasy, MD

Dr. Skardarasy practices at Henry Ford Medical Center - Urgent Care - Waldenburg in Macomb, Michigan.

Dr. Skardarasy's NPI, 1386618882, was assigned on February 14, 2006. Dr. Skardarasy holds Michigan license 047519.

Dr. Skardarasy's primary practice is Henry Ford Medical Center - Urgent Care - Waldenburg, at 17900 23 Mile Rd, Macomb, MI 48044. The practice phone is (248) 680-8121.

Dr. Skardarasy's primary practice is Henry Ford Medical Center - Urgent Care - Waldenburg in Macomb, Michigan. Dr. Skardarasy is also affiliated with Henry Ford Hospital. The medical group on file is Park Family Practice (Infinity Primary Care, PLLC). Dmand AI also links Dr. Skardarasy to 4 more hospitals, 2 home health agencies, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Skardarasy practices, 10 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Skardarasy's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Skardarasy is licensed in Michigan.

CMS data shows 1,459 Medicare services from Dr. Skardarasy across 15 procedure codes in 2024, for 305 Medicare patients. Medicare paid $107,717 for them. Every service was in an office.

CMS counts 305 Medicare patients who saw Dr. Skardarasy in 2024. The largest group is 65 to 74, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Skardarasy's median patient age at 70, with 46% women.

In 2024, Dr. Skardarasy wrote 12,454 Medicare Part D claims for 827 patients. 83% of them were for generic drugs. CMS names the drug for 11,666 of them, across 145 drugs with 11 or more claims each, at $1,591,258 in total drug cost. In 2023, CMS named 12,100 claims across 150 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Skardarasy for performance year 2024, reported through an alternative payment model (APM). Dr. Skardarasy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Skardarasy as offering telehealth.

CMS Open Payments shows 236 general payments to Dr. Skardarasy from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novo Nordisk Inc paid the most, $1,206.